Federica Di Nicolantonio

About Federica Di Nicolantonio

Federica Di Nicolantonio, With an exceptional h-index of 59 and a recent h-index of 49 (since 2020), a distinguished researcher at Università degli Studi di Torino, specializes in the field of Liquid Biopsy, Colorectal cancer, Cancer Epigenetics, Cancer Biomarkers, Molecular diagnostics.

His recent articles reflect a diverse array of research interests and contributions to the field:

FASEB JOURNAL (2014)

Immune surveillance of chemotherapy-induced mutant subclones in CRC

Transcriptome‐wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer

Preclinical efficacy of carfilzomib in BRAF‐mutant colorectal cancer models

Non-canonical antigens are the largest fraction of peptides presented by MHC class I in mismatch repair deficient murine colorectal cancer

Tolerance to colibactin correlates with homologous recombination proficiency and resistance to irinotecan in colorectal cancer cells

Abstract B005: Tolerance to colibactin correlates with response to chemotherapeutic agents in colorectal cancer

Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance

Federica Di Nicolantonio Information

University

Position

Dept of Oncology & Candiolo Cancer Institute FPO - IRCCS

Citations(all)

26732

Citations(since 2020)

11669

Cited By

20198

hIndex(all)

59

hIndex(since 2020)

49

i10Index(all)

121

i10Index(since 2020)

97

Email

University Profile Page

Google Scholar

Federica Di Nicolantonio Skills & Research Interests

Liquid Biopsy

Colorectal cancer

Cancer Epigenetics

Cancer Biomarkers

Molecular diagnostics

Top articles of Federica Di Nicolantonio

FASEB JOURNAL (2014)

2023/1/16

Immune surveillance of chemotherapy-induced mutant subclones in CRC

Cancer Research

2024/3/22

Federica Di Nicolantonio
Federica Di Nicolantonio

H-Index: 42

Alberto Bardelli
Alberto Bardelli

H-Index: 76

Transcriptome‐wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer

Molecular Oncology

2024/3/11

Preclinical efficacy of carfilzomib in BRAF‐mutant colorectal cancer models

Molecular Oncology

2024/2/13

Alberto Bardelli
Alberto Bardelli

H-Index: 76

Federica Di Nicolantonio
Federica Di Nicolantonio

H-Index: 42

Non-canonical antigens are the largest fraction of peptides presented by MHC class I in mismatch repair deficient murine colorectal cancer

Genome Medicine

2024/1/19

Tolerance to colibactin correlates with homologous recombination proficiency and resistance to irinotecan in colorectal cancer cells

Cell Reports Medicine

2024/1/15

Abstract B005: Tolerance to colibactin correlates with response to chemotherapeutic agents in colorectal cancer

Cancer Research

2024/1/9

Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance

Cancer Cell

2023/1/9

Bcl-xL Is a Key Mediator of Apoptosis Following KRASG12C Inhibition in KRASG12C-mutant Colorectal Cancer

Molecular Cancer Therapeutics

2023/1/3

European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission

2023/1/1

Abstract A001: Reshaping the immune microenvironment after temozolomide priming in metastatic colorectal cancer patients in ARETHUSA clinical trial

Cancer Immunology Research

2023/12/1

Circulating tumor DNA to drive treatment in metastatic colorectal cancer

2023/11/14

2235P Chemotherapy priming leads to hypermutability and immune surveillance in colorectal cancer

Annals of Oncology

2023/10/1

18P Exposure of calreticulin is required for vitamin C immunomediated cancer surveillance

Annals of Oncology

2023/10/1

Dual VEGFA/BRAF targeting boosts PD‐1 blockade in melanoma through GM‐CSF‐mediated infiltration of M1 macrophages

Molecular Oncology

2023/8

High-dose vitamin C to enhance neoadjuvant immune checkpoint therapy in mismatch repair proficient colon cancer: The ALFEO pilot study.

2023/6/1

Precision oncology for KRASG12C-mutant colorectal cancer

2023/6

Federica Di Nicolantonio
Federica Di Nicolantonio

H-Index: 42

Alberto Bardelli
Alberto Bardelli

H-Index: 76

Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity

Journal of Experimental & Clinical Cancer Research

2023/5/12

Abstract LB058: A transcriptome-wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer

Cancer Research

2023/4/14

Tolerance to colibactin correlates with response to chemotherapeutic agents in colorectal cancer

Cancer Research

2023/4/4

See List of Professors in Federica Di Nicolantonio University(Università degli Studi di Torino)

Co-Authors

academic-engine